# Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema

> **NCT04014556** · NA · COMPLETED · sponsor: **University of Alexandria** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DEVICE:** micropulse laser
- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT04014556
- **Lead sponsor:** University of Alexandria
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04014556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04014556, "Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04014556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*